Skip to main content
. Author manuscript; available in PMC: 2010 Jun 1.
Published in final edited form as: Acta Neuropathol. 2009 Apr 28;117(6):613–634. doi: 10.1007/s00401-009-0538-8

Table 2.

Cognitive and neuromotor screening test results for the study subjects, in terms of Mini Mental State Examination (MMSE) and motor scores (part 3) from the Unified Parkinson’s Disease Rating Scale (UPDRS). The time elapsed since the last clinical testing dates are given. Note that only a subset of the subjects listed in Table 1 had data available. Means and standard deviations are given where noted.

Diagnosis MMSE (SD) N1 MMSE – Months Before Death (SD)2 UPDRS (SD)3 UPDRS - Months Before Death (SD)4
Normal 28.6 (1.5) 54 21.2 (16.7) 9.8 (9.7) 55 14.3 (11.3)
ILBD 27.8 (2.0) 15 16.7 (13.2) 7.8 (4.2) 18 15.8 (12.3)
PD 20.3 (8.7) 39 16.8 (13.8) 41.0 (22.5) 27 15.1 (17.1)
DLB 12.9 (8.9) 26 13.4 (14.7) 52.1 (26.0) 9 14.2 (9.2)
ADLB 9.9 (7.9) 54 15.0 (12.7) 31.5 (28.6) 19 22.3 (26.0)
ADNLB 11.1 (8.0) 68 15.1 (13.5) 28.0 (23.4) 25 24.4 (20.8)
1

Group means were significantly different (p < 0.0001).

2

Group means were not significantly different.

3

Group means were significantly different (p < 0.0001).

4

Group means were not significantly different.

Abbreviations as given in Table 1.